Change template to: full
Articles
Retrovirus mediated hematopoietic gene therapy: A European regulatory perspective with special focus on the situation in Germany
Christine Voelkel1,2, Anke Lührmann2, Christopher Baum1,3, and Heiko E. von der Leyen2
Ongoing dynamics in the regulatory landscape of human embryonic stem cell research
Anja Elstner*1, Annette Noack*1, Alexander Damaschun1, Glyn Stacey2, Begoňa Arán3, Ilona Gawronska1, Anna Veiga3,4,
Joeri Borstlap1 and Andreas Kurtz1
* Both authors contributed equally
Autologous mesenchymal stromal cells of hemoblastosis patients efficiently support hematopoietic recovery after stem cell transplantation
Vera V. Sergeevicheva1, Ekaterina Y. Shevela1, Svetlana A. Sizikova1, Alexander D. Kulagin2, Irina V. Kruchkova1,
Andrey V. Gilevich1, Igor A. Lisukov2, Vladimir A. Kozlov1, Alexander A. Ostanin1, Elena R. Chernykh1
The MSCs' in vitro community: where to go?
Sascha Lange, Axel R. Zander, Claudia Lange